DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Novartis (NYSE: NVS)

96.49 -0.38 (-0.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $96.49 -0.39%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.02
Previous Close $96.87
Daily Range $96.05 - $98.02
52-Week Range $77.90 - $102.59
Market Cap $233.4B
P/E Ratio 26.18
Dividend (Yield) $2.72 (2.4%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 4,615,576
Average Daily Volume 2,193,106
Current FY EPS $5.19

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales

Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.

Bristol Myers Squibb: What To Expect In Q4 2014 And Beyond

Trio Of Wall Street Firms Up Array BioPharma Price Targets

This Study Offers a Terrifying Revelation on the Future Cost of Cancer

Cancer drug spending could approach $100 billion by 2018.

This Stock Could Become the Next Johnson & Johnson

Our Motley Fool contributors think that these three companies could one day be as revered as J&J.

Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog

Pharmaceuticals Sector To See High Voltage Action in 2015

Health Care Sector Update for 01/23/2015: RMD,ARRY,NVS,UPI

Health Care Sector Update for 01/23/2015: ISRG,ARRY,NVS,UPI

Why Array Biopharma Inc's Shares Skyrocketed

Is this meaningful? Or just another movement?

See More NVS News...

NVS's Top Competitors

NVS $96.49 (-0.39%)
Current stock: NVS
JNJ $102.26 (0.06%)
Current stock: JNJ
MRK $62.82 (0.53%)
Current stock: MRK
GSK $45.19 (0.40%)
Current stock: GSK